Sétha Douc‐Rasy

High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in normal epithelium and in early non-invasive lesions.

J.C. Ahomadegbe, Michel Barrois, Sandy Fogel et al. · PubMed · 1995 · 198 citations

Medicine, Oncology, Pathology +14

Netrin-1 acts as a survival factor for aggressive neuroblastoma

Céline Delloye‐Bourgeois, Julien Fitamant, Andréa Paradisi et al. · The Journal of Experimental Medicine · 2009 · 124 citations · Full text

Medicine, Cancer Biology, Oncology +15

High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas. Uncoupling of H19 and IGF2 expression and biallelic hypomethylation of H19.

Sétha Douc‐Rasy, Michel Barrois, Sandy Fogel et al. · PubMed · 1996 · 113 citations

Medicine, Genetics, Molecular Genetics +16

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

C-H Gattolliat, Laurent F. Thomas, Silvia Anna Ciafrè et al. · British Journal of Cancer · 2011 · 99 citations · Full text

Medicine, Molecular Biology, Oncology +16

CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells

Karima Bettayeb, Claire Delehouzé, Nadège Loaëc et al. · Genes & Cancer · 2010 · 86 citations · Full text

Medicine, Oncology, Pharmacology +15